Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation

Summary

This research study will test how well hyperpigmentation treatment works for subjects with mild-to-moderate facial hyperpigmentation. The study will also test if the hyperpigmentation treatment causes any irritation. For 12 weeks of the study, participants will use the assigned treatment, along with a provided cleanser and sunscreen.

Timeline

Start

2025-01-01

Primary completion

2025-05-10

Completion

2025-12-15

Outcome

Outcome not reported

Stopped: “This study had been withdrawn by the sponsor as they are in process to approach FDA with rationale to get agency feedback and share written response on IRB query. Thereafter, they may again approach with new application and FDA written response.”

Drugs

Indications